These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 33647579)

  • 1. Population pharmacokinetic/pharmacodynamic modeling of delayed effect of escitalopram-induced QT prolongation.
    Kim Y; Kim A; Chung JY
    J Affect Disord; 2021 Apr; 285():120-126. PubMed ID: 33647579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics and pharmacodynamics of escitalopram in overdose and the effect of activated charcoal.
    van Gorp F; Duffull S; Hackett LP; Isbister GK
    Br J Clin Pharmacol; 2012 Mar; 73(3):402-10. PubMed ID: 21883384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics of moxifloxacin and its concentration-QT interval relationship modeling in Chinese healthy volunteers.
    Xu FY; Huang JH; He YC; Liang LY; Li LJ; Yang J; Yin F; Xu L; Zheng QS; Wang K
    Acta Pharmacol Sin; 2017 Nov; 38(11):1580-1588. PubMed ID: 28713157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A thorough QT study to evaluate the QTc prolongation potential of two neuropsychiatric drugs, quetiapine and escitalopram, in healthy volunteers.
    Kim A; Lim KS; Lee H; Chung H; Yoon SH; Yu KS; Cho JY; Jang IJ; Chung JY
    Int Clin Psychopharmacol; 2016 Jul; 31(4):210-7. PubMed ID: 26950553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Escitalopram-induced QTc prolongation and its relationship with KCNQ1, KCNE1, and KCNH2 gene polymorphisms.
    Chen Z; Xu Z; Gao C; Chen L; Tan T; Jiang W; Chen B; Yuan Y; Zhang Z
    J Affect Disord; 2024 Feb; 347():399-405. PubMed ID: 38000475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic-pharmacodynamic analysis to evaluate the effect of moxifloxacin on QT interval prolongation in healthy Korean male subjects.
    Hong T; Han S; Lee J; Jeon S; Park GJ; Park WS; Lim KS; Chung JY; Yu KS; Yim DS
    Drug Des Devel Ther; 2015; 9():1233-45. PubMed ID: 25750520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thorough QT study of the effect of oral moxifloxacin on QTc interval in the fed and fasted state in healthy Japanese and Caucasian subjects.
    Taubel J; Ferber G; Lorch U; Batchvarov V; Savelieva I; Camm AJ
    Br J Clin Pharmacol; 2014 Jan; 77(1):170-9. PubMed ID: 23713767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic-pharmacodynamic modeling in the data analysis and interpretation of drug-induced QT/QTc prolongation.
    Piotrovsky V
    AAPS J; 2005 Oct; 7(3):E609-24. PubMed ID: 16353940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PK/PD modeling of a clazosentan thorough QT study with hysteresis in concentration-QT and RR-QT.
    Henrich A; Juif PE; Dingemanse J; Krause A
    J Pharmacokinet Pharmacodyn; 2021 Apr; 48(2):213-224. PubMed ID: 33389549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between citalopram, escitalopram and QTc prolongation in a real-world geriatric setting.
    Crépeau-Gendron G; Brown HK; Shorey C; Madan R; Szabuniewicz C; Koh S; Veinish S; Mah L
    J Affect Disord; 2019 May; 250():341-345. PubMed ID: 30877856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of QT prolongation with serotonin reuptake inhibitors.
    Ojero-Senard A; Benevent J; Bondon-Guitton E; Durrieu G; Chebane L; Araujo M; Montastruc F; Montastruc JL
    Psychopharmacology (Berl); 2017 Oct; 234(20):3075-3081. PubMed ID: 28770276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic-pharmacodynamic modelling of QT interval prolongation following citalopram overdoses.
    Friberg LE; Isbister GK; Duffull SB
    Br J Clin Pharmacol; 2006 Feb; 61(2):177-90. PubMed ID: 16433872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic-pharmacodynamic modelling of the effect of Moxifloxacin on QTc prolongation in telemetered cynomolgus monkeys.
    Watson KJ; Gorczyca WP; Umland J; Zhang Y; Chen X; Sun SZ; Fermini B; Holbrook M; Van Der Graaf PH
    J Pharmacol Toxicol Methods; 2011; 63(3):304-13. PubMed ID: 21419854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A genetic-based population PK/PD modeling of methadone in Chinese opiate dependence patients.
    Guo D; Tan Z; Lou X; Shi S; Shu Y; Zhou H; Yu L; Yang H
    Eur J Clin Pharmacol; 2022 Apr; 78(4):565-578. PubMed ID: 35013802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of QTc prolongation model incorporating circadian rhythm using harmonic model.
    Back HM; Lee JH; Yun HY; Kwon KI
    Xenobiotica; 2015 May; 45(5):420-7. PubMed ID: 25475996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approach to Evaluating QT Prolongation of Quetiapine Fumarate in Late Stage of Clinical Development Using Concentration-QTc Modeling and Simulation in Japanese Patients With Bipolar Disorder.
    Fukushi R; Nomura Y; Katashima M; Komatsu K; Sato Y; Takada A
    Clin Ther; 2020 Aug; 42(8):1483-1493.e1. PubMed ID: 32792252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects.
    Dixon R; Job S; Oliver R; Tompson D; Wright JG; Maltby K; Lorch U; Taubel J
    Br J Clin Pharmacol; 2008 Sep; 66(3):396-404. PubMed ID: 18662287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged QTc interval due to escitalopram overdose.
    Mohammed R; Norton J; Geraci SA; Newman DB; Koch CA
    J Miss State Med Assoc; 2010 Dec; 51(12):350-3. PubMed ID: 21370605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative relationship between myocardial concentration of tacrolimus and QT prolongation in guinea pigs: pharmacokinetic/pharmacodynamic model incorporating a site of adverse effect.
    Minematsu T; Ohtani H; Yamada Y; Sawada Y; Sato H; Iga T
    J Pharmacokinet Pharmacodyn; 2001 Dec; 28(6):533-54. PubMed ID: 11999291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium channel blockade with QRS widening after an escitalopram overdose.
    Schreffler SM; Marraffa JM; Stork CM; Mackey J
    Pediatr Emerg Care; 2013 Sep; 29(9):998-1001. PubMed ID: 24201980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.